Observational Study With Everolimus (Certican) in Combination With Low-dose Cyclosporine in De Novo Heart Transplant Recipients
Authors:
- Hans B. LehmkuhlHLHans B. Lehmkuhl
- Daniel MaiDMDaniel Mai
- Michael DandelMDMichael Dandel
- Christoph KnosallaCKChristoph Knosalla
- Nicola E. HiemannNHNicola E. Hiemann
- Onnen GrauhanOGOnnen Grauhan
- Michael HueblerMHMichael Huebler
- Miralem PasicMPMiralem Pasic
- Yuguo WengYWYuguo Weng
- Rudolph MeyerRMRudolph Meyer
- Markus RothenburgerMRMarkus Rothenburger
- Manfred HummelMHManfred Hummel
- 31 July 2007
- journal article
- clinical trial
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 26 (7) , 700-704
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Three-Year Results of a Randomized, Double-Blind, Controlled Trial of Mycophenolate Mofetil Versus Azathioprine in Cardiac Transplant RecipientsThe Journal of Heart and Lung Transplantation, 2005
- From Clinical Trials to Clinical Practice: An Overview of Certican® (Everolimus) in Heart TransplantationThe Journal of Heart and Lung Transplantation, 2005
- Everolimus (Certican) 12-Month Safety and Efficacy Versus Mycophenolate Mofetil in de Novo Renal Transplant RecipientsTransplantation, 2004
- Sirolimus in De Novo Heart Transplant Recipients Reduces Acute Rejection and Prevents Coronary Artery Disease at 2 YearsCirculation, 2004
- Everolimus with Optimized Cyclosporine Dosing in Renal Transplant Recipients: 6-Month Safety and Efficacy Results of Two Randomized StudiesAmerican Journal of Transplantation, 2004
- Everolimus for the Prevention of Allograft Rejection and Vasculopathy in Cardiac-Transplant RecipientsNew England Journal of Medicine, 2003
- Use of Rapamycin Slows Progression of Cardiac Transplantation VasculopathyCirculation, 2003
- What is the optimal prophylaxis for treatment of cardiac allograft vasculopathy?Trials, 2000
- SDZ-RAD PREVENTS MANIFESTATION OF CHRONIC REJECTION IN RAT RENAL ALLOGRAFTSTransplantation, 2000
- SDZ RAD, A NEW RAPAMYCIN DERIVATIVETransplantation, 1997